Developing as a promising advance in the fight against obesity, Retatrutide is generating considerable interest . This treatment combines effects of two established GLP-1 receptor agonists, liraglutide, plus an new glucose-dependent hormonal component. Preliminary study data have indicated impressive fat decrease in patients with obesity , possibl